Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia

Francis J. Giles, Gary Guangping Shi, Jorge E. Cortes, Deborah Thomas, Anna R. Keating, Hagop M. Kantarjian, Michael J. Keating, Susan M. O'Brien

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds